| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/02/2004 | EP1235830B1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS AS PROTEIN KINASES INHIBITORS |
| 01/02/2004 | EP1044187B1 N-benzyl-3-indenylacetamides derivatives for treating neoplasia |
| 01/02/2004 | EP1036062B1 Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors |
| 01/02/2004 | EP0986570B9 Gemcitabine derivatives |
| 01/02/2004 | EP0979103B1 Light imaging contrast agents |
| 01/02/2004 | EP0719343B1 Adeno-associated viral (aav) liposomes and methods related thereto |
| 01/01/2004 | US20040003418 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer |
| 01/01/2004 | US20040002602 Synthetic process for the manufacture of an ecteinaschidin compound |
| 01/01/2004 | US20040002585 Mucin fusion polypeptide vaccines, compositions and methods of use thereof |
| 01/01/2004 | US20040002540 Method for increasing the concentration of ascorbic acid in brain tissues of a subject |
| 01/01/2004 | US20040002535 Methods of treating hormone-related conditions using thio-oxindole derivatives |
| 01/01/2004 | US20040002534 Stem cell factor; signal transduction passageways; anticancer agents |
| 01/01/2004 | US20040002532 Antiinflammatory agents; cyclooxygenase inhibitor; analgesics; antipyretics |
| 01/01/2004 | US20040002528 CBI analogs of CC-1065 and the duocarmycins |
| 01/01/2004 | US20040002524 Cardiovascular disorders; osteoporosis; central nervous system disorders |
| 01/01/2004 | US20040002521 Antiinflammatory agents; metalloprotease inhibitor; antiarthritic agents; antiallergens; viricides |
| 01/01/2004 | US20040002518 Anticancer agents; tyrosine kinase inhibitor; wound healing agents |
| 01/01/2004 | US20040002512 Alpha-substituted carboxylic acid derivatives |
| 01/01/2004 | US20040002511 Novel pyrazolo[1,5-a]pyridine derivatives and their use as neurotransmitter modulators |
| 01/01/2004 | US20040002508 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders |
| 01/01/2004 | US20040002507 Rho-kinase inhibitors |
| 01/01/2004 | US20040002506 Antiproliferative agents; antitumor agents |
| 01/01/2004 | US20040002505 Medicinal compositions for cocominant use as anticancer agent |
| 01/01/2004 | US20040002501 Modulate signal transduction; antitumor, anticancer agents, vision defects, antidiabetic agents, antiinflammatory agents |
| 01/01/2004 | US20040002499 Antitumor agents; anticancer agents; mixture of curcumin and paclitaxel |
| 01/01/2004 | US20040002496 Compositions useful as inhibitors of protein kinases |
| 01/01/2004 | US20040002494 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| 01/01/2004 | US20040002493 Benzoic acid derivatives and pharmaceutical agents comprising the same as active ingredient |
| 01/01/2004 | US20040002491 Melatonergic receptors |
| 01/01/2004 | US20040002490 Melatonergic receptors |
| 01/01/2004 | US20040002482 Androgen pharmaceutical composition and method for treating depression |
| 01/01/2004 | US20040002481 Novel 4-dedimethylaminotetracycline derivatives |
| 01/01/2004 | US20040002476 Modified fluorinated nucleoside analogues |
| 01/01/2004 | US20040002473 Pain modulation; incotinence therapy; central nervous system disorders |
| 01/01/2004 | US20040002459 Nucleic acids encoding kringle 1-5 region fragments of plasminogen |
| 01/01/2004 | US20040002449 METH1 and METH2 polynucleotides and polypeptides |
| 01/01/2004 | US20040002134 Novel nucleic acid sequences encoding human KIAA0768 protein-like and human protein PRO228-like polypeptides |
| 01/01/2004 | US20040002066 36 human secreted proteins |
| 01/01/2004 | US20040001867 Vectors for molecule delivery to CD11b expressing cells |
| 01/01/2004 | US20040001852 Deactivation antigen protein; anticancer agents; Aids therapy |
| 01/01/2004 | US20040001844 Lewis Y epitope-containing mucin fusion polypeptide vaccines, compositions and methods of use thereof |
| 01/01/2004 | US20040001841 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 01/01/2004 | US20040001840 Cancer-linked gene as target for chemotherapy |
| 01/01/2004 | US20040001838 Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same |
| 01/01/2004 | US20040001835 Prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents |
| 01/01/2004 | US20040001833 Method of treating cancer using kinase inhibitors |
| 01/01/2004 | US20040001828 Treatment methods using anti-CD22 antibodies |
| 01/01/2004 | US20040001824 Cell proliferation inhibitors |
| 01/01/2004 | US20040001818 Prevention endothelial cell migration; antiproliferative agent; diaphorase inhibitor |
| 01/01/2004 | US20040001811 Compositions and methods for inhibiting expression of anti-apoptotic genes |
| 01/01/2004 | US20040001806 Culture product containing interleukins and colony stimulanting factor; antitumor agents |
| 01/01/2004 | US20040001802 Immobilized tumor necrosis factor |
| 01/01/2004 | US20040001790 Methods for diagnosis and treatment of tumours |
| 01/01/2004 | US20040001789 Diagnosis, cancer therapy; using monoclonal antibodies |
| 12/31/2003 | WO2004001381A2 Novel raag10 cell surface target and a family of antibodies recognizing that target |
| 12/31/2003 | WO2004001072A2 Method for diagnosis of colorectal tumors |
| 12/31/2003 | WO2004001059A2 Heterocyclic inhibitors of kinases |
| 12/31/2003 | WO2004001048A1 Pharmaceutical composition and method of treatment of human malignancies with arginine deprivation |
| 12/31/2003 | WO2004001026A1 Method of preparing recombinant mononegaviruses and the applications thereof |
| 12/31/2003 | WO2004001007A2 Buffered formulations for concentrating antibodies and methods of use thereof |
| 12/31/2003 | WO2004001004A2 Membrane associated tumor endothelium markers |
| 12/31/2003 | WO2004000887A1 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same |
| 12/31/2003 | WO2004000854A1 Sulfur-containing phospholipid derivatives |
| 12/31/2003 | WO2004000846A1 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 12/31/2003 | WO2004000839A1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 12/31/2003 | WO2004000834A1 Novel 3-(4-oxo-4h-chromen-2-yl)-(1h)-quinoline-4-one derivatives, method for preparing same and pharmaceutical compositions containing same |
| 12/31/2003 | WO2004000833A1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase |
| 12/31/2003 | WO2004000822A1 2-thioxothiazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 12/31/2003 | WO2004000820A2 Certain aromatic monocycles as kinase modulators |
| 12/31/2003 | WO2004000817A2 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 12/31/2003 | WO2004000816A1 Androgen receptor agonist |
| 12/31/2003 | WO2004000807A1 Cannabinoid receptor agonists |
| 12/31/2003 | WO2004000801A2 Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions |
| 12/31/2003 | WO2004000781A2 Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 12/31/2003 | WO2004000369A2 Method of magnetically manipulating a cell with magnetisable particles |
| 12/31/2003 | WO2004000365A1 Drug transport and delivery system |
| 12/31/2003 | WO2004000362A1 Process for producing block copolymer/drug composite |
| 12/31/2003 | WO2004000356A1 Medicinal composition containing diuretic and peroxisome proliferator-activated receptor (ppar) ϝ actiavtor |
| 12/31/2003 | WO2004000349A1 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation |
| 12/31/2003 | WO2004000346A1 Preventives/remedies for cancer |
| 12/31/2003 | WO2004000344A1 Aqueous preparation containing oligopeptides and etherified cyclodextrin |
| 12/31/2003 | WO2004000333A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 12/31/2003 | WO2004000324A1 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 12/31/2003 | WO2004000322A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis |
| 12/31/2003 | WO2004000321A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis |
| 12/31/2003 | WO2004000314A1 Methods of using benzothiophenone derivatives to treat cancer or inflammation |
| 12/31/2003 | WO2004000307A1 Novel use of ansamycin antibiotics and method of screening novel angiogenesis inhibitor |
| 12/31/2003 | WO2004000301A1 Oral preventive/therapeutic agent for skin damage containing diacylglyceryl ether |
| 12/31/2003 | WO2004000294A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 12/31/2003 | WO2004000287A1 Targeting system comprising uniformly-sized nanoparticles with at least one polymer and at least one positively-charged polysaccharide and preparation method thereof |
| 12/31/2003 | WO2004000237A2 Enhancing treatment of mdr cancer with adenosine a3 antagonists |
| 12/31/2003 | WO2004000230A2 Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders |
| 12/31/2003 | WO2004000229A2 Treatment of human multiple myeloma by curcumin |
| 12/31/2003 | WO2004000225A2 Use of thio-oxindole derivatives in treatment of hormone-related conditions |
| 12/31/2003 | WO2004000206A2 Pyrazole-3-one derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 12/31/2003 | WO2004000204A2 Labelled somatostatin analogs backbone cyclized through metal complexation |
| 12/31/2003 | WO2004000042A2 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 12/31/2003 | WO2003094911B1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 12/31/2003 | WO2003087308A3 Use of interleukin-24 to treat ovarian cancer |
| 12/31/2003 | WO2003077832A3 Dexanabinol and dexanabinol analogs regulate inflammation related genes |